Section
Policy
IRA, state PBM reform, Medicare, and regulatory action
Policy
State PBM rules in 2025-2026 mean new six-figure legal and data costs for independents, while chains like CVS …
Policy
In its inaugural round, CMS demanded deep price cuts on blockbuster drugs under the IRA. Drugmakers pushed bac…
Policy
First-round IRA negotiations saw average price cut offers near 29 percent, but some manufacturers accepted con…
Policy
The IRA Part D redesign shifts billions in catastrophic costs to manufacturers. Here is who gets hit hardest.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.